Mucosal Neisseria gonorrhoeae coinfection during HIV acquisition is associated with enhanced systemic HIV-specific CD8 T-cell responses

AIDS

Volumn 22, Issue 14, 2008, Pages 1729-1737

  Sheung, Anthony ^a   Rebbapragada, Anu ^a   Shin, Lucy Y Y ^a   Dobson Belaire, Wendy ^a   Kimani, Joshua ^b   Ngugi, Elizabeth ^b   MacDonald, Kelly S ^a,c   Bwayo, Job J ^b   Moses, Stephen ^d   Gray Owen, Scott ^a   Kaul, Rupert ^a,e,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

CD8 T cells; Female sex workers; Gonorrhea; HIV; Mucosal immunology

Indexed keywords

GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; GENITAL TRACT INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MIXED INFECTION; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE;

ADULT; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL4; DEVELOPING COUNTRIES; FEMALE; GONORRHEA; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; KENYA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEISSERIA GONORRHOEAE; PROSTITUTION; VIRAL LOAD;

EID: 66349117108     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32830baf5e     Document Type: Article

References (39)

1. Cohen MS. HIV and sexually transmitted diseases: lethal synergy. Top HIV Med 2004; 12:104-107.
2. Wald A, Corey L. How does herpes simplex virus type 2 influence human immunodeficiency virus infection and patho-genesis? J Infect Dis 2003; 187:1509-1512.
3. Rebbapragada A, Wachihi C, Pettengell C, Sunderji S, Huibner S, Jaoko W, et al. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS 2007; 21:589-598.
4. Kaul R, Pettengell C, Sheth PM, Sunderji S, Biringer A, Macdonald K, et al. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol 2008; 77:32-40.
5. Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2004; 2:33-42.
6. Letvin NL. Correlates of immune protection and the development of a human immunodeficiency virus vaccine. Immunity 2007; 27:366-369.
7. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007; 27:406-416.
8. Price DA, Goulder PJ, Klenerman P, Sewell AK, Easterbrook PJ, Troop M, et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A1 997; 94:1890-1895.
9. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001; 412:334-338.
10. McMichael AJ, Rowland-Jones SL. Cellular immune responses to HIV. Nature 2001; 410:980-987.
11. Anzala AO, Simonsen JN, Kimani J, Ball TB, Nagelkerke NJ, Rutherford J, et al. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. J Infect Dis 2000; 182:459-466.
12. Kaul R, Rowland-Jones SL, GillespieG, KimaniJ, DongT, Kiama P, et al. Gonococcal cervicitis is associated with reduced systemic CD8R T cell responses in human immunodeficiency virus type 1-infected and exposed, uninfected sex workers. J Infect Dis 2002; 185:1 525-1 529.
13. Boulton IC, Gray-Owen SD. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4R T lymphocytes. Nat Immunol 2002; 3:229-236.
14. Yu Q, Chow E, Yue E, Kovacs C, Dimayuga R, Loutfy M, et al. A dangerous liaison between two major STD pathogens, HIV and Neisseria gonorrhoeae: Opa52 protein of Neisseria gonor-rhoeae impairs dendritic cell maturation and subsequent HIV-specific T cell immunity. In: Keystone Conference on the Molecular Mechanisms of HIV Pathogenesis. Whistler, British Columbia, Canada, April 2004 [abstract 454].
15. Anzala OA, Nagelkerke NJ, BwayoJJ, Holton D, Moses S, Ngugi EN, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995; 171:686-689.
16. Venier C, Guthmann MD, Fernandez LE, Fainboim L. Innate-immunity cytokines induced by very small size proteolipo-somes, a Neisseria-derived immunological adjuvant. Clin Exp Immunol 2007; 147:379-388.
17. Mesa C, de Leon J, Rigley K, Fernandez LE. Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for dendritic cell activation. Vaccine 2006; 24 (Suppl 2):S42-S43.
18. Grothaus MC, Srivastava N, Smithson SL, Kieber-Emmons T, Williams DB, Carlone GM, Westerink MA. Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library. Vaccine 2000; 18:1253-1263.
19. Liu X, Mosoian A, Li-Yun Chang T, Zerhouni-Layachi B, Snyder A, Jarvis GA, Klotman ME. Gonococcal lipooligosaccharide suppresses HIV infection in human primary macrophages through induction of innate immunity. J Infect Dis 2006; 194:751-759.
20. Wang Y, Abel K, Lantz K, Krieg AM, McChesney MB, Miller CJ. The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J Virol 2005; 79:14355-14370.
21. Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Ngugi EN, Keli F, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 2004; 291:2555-2562.
22. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
23. Kaul R, Rowland-Jones SL, KimaniJ, DongT, Yang HB, Kiama P, et al. Late seroconversion in HIV-resistant Nairobi prostitutes despite pre existing HIV-specific CD8(R) responses. J Clin Invest 2001; 107:341-349.
24. Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Keli F, MacDonald KS, et al. Reduced HIV risk-taking and low HIV incidence after enrollment and risk- reduction counseling in a sexually transmitted disease prevention trial in Nairobi, Kenya. J Acquir Immune Defic Syndr 2002; 30:69-72.
25. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8R T cells. Blood 2006; 107: 4781-4789.
26. Sheth PM, Sunderji S, Shin LY, Rebbapragada A, Huibner S, Kimani J, et al. Co-infection with Herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. J Infect Dis 2008; 197:1394-1401.
27. Cohen MS, Hoffman IF, Royce RA, Kazembe P, DyerJR, Daly CC, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349:1868-1873.
28. Sena AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis 2007; 44:13-22.
29. Price MA, Stewart SR, Miller WC, Behets F, Dow WH, Martinson FE, et al. The cost-effectiveness of treating male trichomoniasis to avert HIV transmission in men seeking sexually transmitted disease care in Malawi. J Acquir Immune Defic Syndr 2006; 43:202-209.
30. Winter AJ, Taylor S, Workman J, White D, RossJD, Swan AV, Pillay D. Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma. Sex Transm Infect 1999; 75:261-263.
31. McClelland RS, Wang CC, Mandaliya K, Overbaugh J, Reiner MT, Panteleeff DD, et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 2001; 15:105-110.
32. Meyers JH, Justement JS, Hallahan CW, Blair ET, Sun YA, O'Shea MA, et al. Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cells. PLoS ONE 2007; 2:e458.
33. Hoebe K. The innate-adaptive connection: TLRs and beyond. In: Keystone Symposia on HIV Vaccines (X7); Whistler, B.C. 2007.
34. Massari P, Ram S, Macleod H, Wetzler LM. The role of porins in neisserial pathogenesis and immunity. Trends Microbiol 2003; 11:87-93.
35. Agadjanyan MG, Kim JJ, Trivedi N, Wilson DM, Monzavi-Karbassi B, Morrison LD, et al. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. I Immunol 1999; 162:3417-3427.
36. Montano M, Rarick M, Sebastiani P, Brinkmann P, Skefos J, Ericksen R. HIV-1 burden influences host response to co-infection with Neisseria gonorrhoeae in vitro. Int Immunol 2006; 18:125-137.
37. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8R T-cells. Blood 2006; 107:4781-4789.
38. Dowling WE, Kim B, Mason CJ, Wasunna KM, Alam U, Elson L, et al. Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombi-nants. AIDS 2002; 16:1809-1820.
39. McKinnon LR, Ball TB, Kimani J, Wachihi C, Matu L, Luo M, et al. Cross-clade CD8(R) T-cell responses with a preference for the predominant circulating clade. J Acquir Immune Defic Syndr 2005; 40:245-249.